S

Scientific and Medical Equipment House Company CJSC
SAU:4014

Watchlist Manager
Scientific and Medical Equipment House Company CJSC
SAU:4014
Watchlist
Price: 53.8 SAR -0.37% Market Closed
Market Cap: 1.6B SAR
Have any thoughts about
Scientific and Medical Equipment House Company CJSC?
Write Note
Section:
 

Relative Value

The Relative Value of one Scientific and Medical Equipment House Company CJSC stock under the Base Case scenario is 56.35 SAR. Compared to the current market price of 53.8 SAR, Scientific and Medical Equipment House Company CJSC is Undervalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
56.35 SAR
Undervaluation 5%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

1.8
P/S
P/S
Price to Sales
1.8
vs History
60
vs Industry
50
Median 3Y
1.8
Median 5Y
1.8
Industry
2.3
Forward
1.6
More Details
39.4
P/E
P/E
Price to Earnings
39.4
vs History
28
vs Industry
13
Median 3Y
35.4
Median 5Y
35.4
Industry
23.2
Forward
26.4
More Details
6.4
P/OCF
P/OCF
Price to OCF
6.4
vs History
42
vs Industry
33
Median 3Y
6.4
Median 5Y
6.4
Industry
14.3
More Details
16.8
P/FCFE
P/FCFE
Price to FCFE
16.8
vs History
42
vs Industry
14
Median 3Y
16.8
Median 5Y
16.8
Industry
20.1
More Details
3
P/B
P/B
Price to Book Value
3
vs History
37
vs Industry
26
Median 3Y
3
Median 5Y
3
Industry
2.2
More Details
1.7
EV/S
EV/S
Enterprise Value to Sales
1.7
vs History
71
vs Industry
50
Median 3Y
1.9
Median 5Y
1.9
Industry
2.4
Forward
1.5
More Details
10.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.8
vs History
22
vs Industry
18
Median 3Y
10.4
Median 5Y
10.4
Industry
5
More Details
16.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.8
vs History
45
vs Industry
20
Median 3Y
16.8
Median 5Y
16.8
Industry
12.8
Forward
13
More Details
21.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.7
vs History
37
vs Industry
20
Median 3Y
21.7
Median 5Y
21.7
Industry
17.2
Forward
17.7
More Details
6.1
EV/OCF
EV/OCF
Enterprise Value to OCF
6.1
vs History
42
vs Industry
31
Median 3Y
6.1
Median 5Y
6.1
Industry
14
More Details
6.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
6.2
vs History
34
vs Industry
27
Median 3Y
-9.2
Median 5Y
-9.2
Industry
18.2
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
42
vs Industry
43
Median 3Y
1.8
Median 5Y
1.8
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Scientific and Medical Equipment House Company CJSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Scientific and Medical Equipment House Company CJSC
SAU:4014
1.6B SAR 1.8 39.4 16.8 21.7
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.